How Effective, Safe is Mosunetuzumab/Polatuzumab Vedotin in Pretreated MCL?
Results from a phase 2 trial (NCT03671018) that evaluated mosunetuzumab-axgb (Lunsumio) plus polatuzumab vedotin-piiq (Polivy) showed that, in all patients...
effective
Review reveals how to achieve effective ‘virtual wards’ for patients at risk of frailty crisis and ease pressures on the NHS
Published: 14 March 2024An NIHR funded report explores how 'virtual wards' can work optimally to treat people at high risk of...
